ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

GRDN vs RDGT // EV/EBITDA & P/E VALUATION

Guardian Pharmacy Services Inc. (Class A) (NYSE) VS. Ridgetech Inc. (NASDAQ) • 15-METRIC TALLY: GRDN 7 — RDGT 0
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRDN VS. RDGT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC GRDN RDGT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 20.20% 3.60% +16.60 GRDN /gross-margins <GO>
Return on Invested Capital (ROIC) 37.70% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 34.3x — — TIE /valuation <GO>
Free Cash Flow Yield 3.91% — — TIE /fcf-yield <GO>
Operating Margin 5.00% -1.40% +6.40 GRDN /operating-margins <GO>
Net Profit Margin 3.40% -0.90% +4.30 GRDN /net-margins <GO>
Revenue Growth (YoY) 17.90% 10.20% +7.70 GRDN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 12.39 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 1/9 +6.00 GRDN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.6 43.9 +6.68 GRDN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 43.8x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.56B $3.0M $2.56B GRDN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR GRDN REV RDGT REV GRDN GROSS % RDGT GROSS % GRDN FCF RDGT FCF
FY 2025 $1.45B $132.2M 20.2% 3.6% $100.3M -$1.4M
FY 2024 $1.23B $120.0M 19.9% 3.2% $58.0M $1.1M
FY 2023 — $124.0M — — — -$3.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRDN // BETA —
RDGT // BETA —